Leaders from 17 countries are working to improve the health and nutritional well-being of adolescent girls and young women.

OHSU Knight Cancer Institute has been awarded the National Cancer Institute’s, NCI, premier status: Comprehensive Cancer Center.

An OHSU pilot study suggests the over-the-counter antioxidant lipoic acid holds promise in improving the lives of patients with secondary progressive multiple sclerosis.

A new study shows the incidence of cardiac arrests declined significantly among people who acquired health insurance through the Affordable Care Act.

Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.

A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.